Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands

被引：16

作者：

Biersack, Bernhard ^{[1
]}

机构：

[1] Univ Bayreuth, Organ Chem Lab, Univ Str 30, D-95440 Bayreuth, Germany

来源：

MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2016年 / 16卷 / 10期

关键词：

Anticancer drugs; (Arene)Ru(II); DNA binding; Metastasis; Organometallic compounds; Ruthenium; HALF-SANDWICH COMPLEXES; IN-VITRO; ANTITUMOR-ACTIVITY; BIOLOGICAL-ACTIVITY; KINASE INHIBITORS; CELLULAR UPTAKE; DNA-BINDING; DRUGS; CISPLATIN; RU(II);

D O I：

10.2174/138955751610160503004623

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

An overview of anticancer active (arene) ruthenium(II) complexes coordinated to period 2 element-based ligand systems, i.e., carbon-, nitrogen-, and oxygen-coordinated ligands, is provided in this mini-review. A bridge is forged from the large group of anticancer active ruthenium compounds with monodentate and chelating nitrogen ligands via complexes of O,O-chelating ligands to organometallic ruthenium derivatives coordinated to carbon. (Arene) ruthenium(II) complexes with reduced side-effects and enhanced efficacy against cancer are highlighted. Pertinent literature is covered up to 2014.

引用

页码：804 / 814

页数：11

共 50 条

[1] Anticancer Activity and Catalytic Potential of Ruthenium(11)-Arene Complexes with N,O-Donor Ligands
Haghdoost, Mohammad Mehdi
Guard, Juliette
Golbaghi, Golara
Castonguay, Annie
INORGANIC CHEMISTRY, 2018, 57 (13) : 7558 - 7567
[2] Structure-activity relationships for cytotoxic ruthenium(II) arene complexes containing N,N-, N,O-, and O,O-chelating ligands
Habtemariam, Abraha
Melchart, Michael
Fernandez, Rafael
Parsons, Simon
Oswald, Iain D. H.
Parkin, Andrew
Fabbiani, Francesca P. A.
Davidson, James E.
Dawson, Alice
Aird, Rhona E.
Jodrell, Duncan I.
Sadler, Peter J.
JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (23) : 6858 - 6868
[3] Modulating the Anticancer Activity of Ruthenium(II)-Arene Complexes
Clavel, Catherine M.
Paunescu, Emilia
Nowak-Sliwinska, Patrycja
Griffioen, Arjan W.
Scopelliti, Rosario
Dyson, Paul J.
JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (08) : 3356 - 3365
[4] Alkyl scandium complexes coordinated by dianionic O,N,N- and O,N,O-ligands derived from Schiff bases
Gurina, Galina A.
Kissel, Alexander A.
Ob'edkov, Anatoly M.
Cherkasov, Anton, V
Trifonov, Alexander A.
MENDELEEV COMMUNICATIONS, 2021, 31 (05) : 631 - 634
[5] Influence of the Tr-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
Hanif, Muhammad
Meier, Samuel M.
Nazarov, Alexey A.
Risse, Julie
Legin, Anton
Casini, Angela
Jakupec, Michael A.
Keppler, Bernhard K.
Hartinger, Christian G.
FRONTIERS IN CHEMISTRY, 2013, 1 : 1 - 7
[6] Arene Ruthenium(II) Complexes with Phosphorous Ligands as Possible Anticancer Agents
Biancalana, Lorenzo
Pampaloni, Guido
Marchetti, Fabio
CHIMIA, 2017, 71 (09) : 573 - 579
[7] Anticancer activity of multinuclear arene ruthenium complexes coordinated to dendritic polypyridyl scaffolds
Govender, Preshendren
Antonels, Nathan C.
Mattsson, Johan
Renfrew, Anna K.
Dyson, Paul J.
Moss, John R.
Therrien, Bruno
Smith, Gregory S.
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2009, 694 (21) : 3470 - 3476
[8] Ruthenium(II) Arene Anticancer Complexes with Redox-Active Diamine Ligands
Bugarcic, Tijana
Habtemariam, Abraha
Deeth, Robert J.
Fabbiani, Francesca P. A.
Parsons, Simon
Sadler, Peter J.
INORGANIC CHEMISTRY, 2009, 48 (19) : 9444 - 9453
[9] Electrophilic Activation of Oxidized Sulfur Ligands and Implications for the Biological Activity of Ruthenium(II) Arene Anticancer Complexes
Sriskandakumar, Thamayanthy
Behyan, Shirin
Habtemariam, Abraha
Sadler, Peter J.
Kennepohl, Pierre
INORGANIC CHEMISTRY, 2015, 54 (23) : 11574 - 11580
[10] Synthesis, antiproliferative activity and apoptosis-promoting effects of arene ruthenium(II) complexes with N, O chelating ligands
Mohan, Nanjan
Subarkhan, Mohamed Kasim Mohamed
Ramesh, Rengan
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 2018, 859 : 124 - 131

← 1 2 3 4 5 →